Lumsden AB, MacDonald MJ, Kikeri DK, Harker LA, Allen RC. Hemodialysis access graft stenosis: percutaneous transluminal angioplasty. J Surg Res. 1997;68(2):181–5.
Article CAS PubMed Google Scholar
Roy-Chaudhury P, Wang Y, Krishnamoorthy M, Zhang J, Banerjee R, Munda R, Heffelfinger S, Arend L. Cellular phenotypes in human stenotic lesions from haemodialysis vascular access. Nephrol Dial Transpl. 2009;24(9):2786–91.
Manns B, Tonelli M, Yilmaz S, Lee H, Laupland K, Klarenbach S, Radkevich V, Murphy B. Establishment and maintenance of vascular access in incident hemodialysis patients: a prospective cost analysis. J Am Soc Nephrol. 2005;16(1):201–9.
Viecelli AK, Tong A, O’Lone E, Ju A, Hanson CS, Sautenet B, Craig JC, Manns B, Howell M, Chemla E, et al. Report of the standardized outcomes in nephrology-hemodialysis (SONG-HD) consensus workshop on establishing a core outcome measure for hemodialysis vascular access. Am J Kidney Dis. 2018;71(5):690–700.
Lok CE, Huber TS, Lee T, Shenoy S, Yevzlin AS, Abreo K, Allon M, Asif A, Astor BC, Glickman MH, et al. KDOQI clinical practice guideline for vascular access: 2019 update. Am J Kidney Dis. 2020;75(4 Suppl 2):S1–164.
Beathard GA. Percutaneous transvenous angioplasty in the treatment of vascular access stenosis. Kidney Int. 1992;42(6):1390–7.
Article CAS PubMed Google Scholar
Dapunt O, Feurstein M, Rendl KH, Prenner K. Transluminal angioplasty versus conventional operation in the treatment of haemodialysis fistula stenosis: results from a 5-year study. Br J Surg. 1987;74(11):1004–5.
Article CAS PubMed Google Scholar
Glanz S, Gordon D, Butt KM, Hong J, Adamson R, Sclafani SJ. Dialysis access fistulas: treatment of stenoses by transluminal angioplasty. Radiology. 1984;152(3):637–42.
Article CAS PubMed Google Scholar
Tessitore N, Mansueto G, Lipari G, Bedogna V, Tardivo S, Baggio E, Cenzi D, Carbognin G, Poli A, Lupo A. Endovascular versus surgical preemptive repair of forearm arteriovenous fistula juxta-anastomotic stenosis: analysis of data collected prospectively from 1999 to 2004. Clin J Am Soc Nephrol. 2006;1(3):448–54.
Gray RJ, Sacks D, Martin LG, Trerotola SO, Society of Interventional Radiology Technology Assessment C. Reporting standards for percutaneous interventions in dialysis access. J Vasc Interv Radiol. 2003,14(9 Pt 2):S433–42
Manninen HI, Kaukanen ET, Ikaheimo R, Karhapaa P, Lahtinen T, Matsi P, Lampainen E. Brachial arterial access: endovascular treatment of failing Brescia-Cimino hemodialysis fistulas–initial success and long-term results. Radiology. 2001;218(3):711–8.
Article CAS PubMed Google Scholar
Turmel-Rodrigues L, Pengloan J, Rodrigue H, Brillet G, Lataste A, Pierre D, Jourdan JL, Blanchard D. Treatment of failed native arteriovenous fistulae for hemodialysis by interventional radiology. Kidney Int. 2000;57(3):1124–40.
Article CAS PubMed Google Scholar
Clark TW, Hirsch DA, Jindal KJ, Veugelers PJ, LeBlanc J. Outcome and prognostic factors of restenosis after percutaneous treatment of native hemodialysis fistulas. J Vasc Interv Radiol. 2002;13(1):51–9.
Trerotola SO, Kwak A, Clark TW, Mondschein JI, Patel AA, Soulen MC, Stavropoulos SW, Shlansky-Goldberg RD, Solomon JA, Tuite CM, et al. Prospective study of balloon inflation pressures and other technical aspects of hemodialysis access angioplasty. J Vasc Interv Radiol. 2005;16(12):1613–8.
Vesely TM, Pilgram TK. Angioplasty balloon inflation pressures during treatment of hemodialysis graft-related stenoses. J Vasc Interv Radiol. 2006;17(4):623–8.
Elramah M, Boujelbane L, Yevzlin AS, Wakeen M, Astor BC, Chan MR. Dialysis access venous stenosis: treatment with balloon angioplasty 30-second vs. 1-minute inflation times. Hemodial Int. 2015;19(1):108–14.
Forauer AR, Hoffer EK, Homa K. Dialysis access venous stenoses: treatment with balloon angioplasty—1-versus 3-minute inflation times. Radiology. 2008;249(1):375–81.
Leontiev O, Shlansky-Goldberg RD, Stavropoulos SW, Mondschein JI, Itkin M, Clark TW, Trerotola SO. Should all inflow stenoses be treated in failing autogenous hemodialysis fistulae? J Vasc Interv Radiol. 2014;25(4):542–7.
Gelbfish GA. Clinical surveillance and monitoring of arteriovenous access for hemodialysis. Tech Vasc Interv Radiol. 2008;11(3):156–66.
Bountouris I, Kristmundsson T, Dias N, Zdanowski Z, Malina M. Is repeat PTA of a failing hemodialysis Fistula durable? Int J Vasc Med. 2014;2014: 369687.
PubMed PubMed Central Google Scholar
Heye S, Maleux G, Vaninbroukx J, Claes K, Kuypers D, Oyen R. Factors influencing technical success and outcome of percutaneous balloon angioplasty in de novo native hemodialysis arteriovenous fistulas. Eur J Radiol. 2012;81(9):2298–303.
Kanterman RY, Vesely TM, Pilgram TK, Guy BW, Windus DW, Picus D. Dialysis access grafts: anatomic location of venous stenosis and results of angioplasty. Radiology. 1995;195(1):135–9.
Article CAS PubMed Google Scholar
Manou-Stathopoulou S, Robinson EJ, Harvey JJ, Karunanithy N, Calder F, Robson MG. Factors associated with outcome after successful radiological intervention in arteriovenous fistulas: a retrospective cohort. J Vasc Access. 2019;20(6):716–24.
Article PubMed PubMed Central Google Scholar
Rajan DK, Bunston S, Misra S, Pinto R, Lok CE. Dysfunctional autogenous hemodialysis fistulas: outcomes after angioplasty—are there clinical predictors of patency? Radiology. 2004;232(2):508–15.
Safa AA, Valji K, Roberts AC, Ziegler TW, Hye RJ, Oglevie SB. Detection and treatment of dysfunctional hemodialysis access grafts: effect of a surveillance program on graft patency and the incidence of thrombosis. Radiology. 1996;199(3):653–7.
Article CAS PubMed Google Scholar
Rajan DK, Clark TW. Patency of Wallstents placed at the venous anastomosis of dialysis grafts for salvage of angioplasty-induced rupture. Cardiovasc Interv Radiol. 2003;26(3):242–5.
Neuen BL, Gunnarsson R, Baer RA, Tosenovsky P, Green SJ, Golledge J, Mantha ML. Factors associated with patency following angioplasty of hemodialysis fistulae. J Vasc Interv Radiol. 2014;25(9):1419–26.
Holden A, Haruguchi H, Suemitsu K, Isogai N, Ross J, Hull J, Wang H, Seamans J, Lookstein R, Investigators IPAA. IN.PACT AV access randomized trial: 12-month clinical results demonstrating the sustained treatment effect of drug-coated balloons. J Vasc Interv Radiol. 2022;33(8):884–894.e887
Karmota AG. Paclitaxel coated-balloon (PCB) versus standard plain old balloon (POB) fistuloplasty for failing dialysis access. Ann R Coll Surg Engl. 2020;102(8):601–5.
Article CAS PubMed PubMed Central Google Scholar
Karunanithy N, Robinson EJ, Ahmad F, Burton JO, Calder F, Coles S, Das N, Dorling A, Forman C, Jaffer O, et al. A multicenter randomized controlled trial indicates that paclitaxel-coated balloons provide no benefit for arteriovenous fistulas. Kidney Int. 2021;100(2):447–56.
Article CAS PubMed Google Scholar
Lookstein RA, Haruguchi H, Holden A. Drug-coated balloons for dysfunctional dialysis arteriovenous fistulas. Reply. N Engl J Med. 2021;384(12):1173–4.
Maleux G, Vander Mijnsbrugge W, Henroteaux D, Laenen A, Cornelissen S, Claes K, Fourneau I, Verbeeck N. Multicenter, randomized trial of conventional balloon angioplasty versus paclitaxel-coated balloon angioplasty for the treatment of dysfunctioning autologous dialysis fistulae. J Vasc Interv Radiol. 2018;29(4):470–75 e473
Moreno-Sanchez T, Moreno-Ramirez M, Machancoses FH, Pardo-Moreno P, Navarro-Vergara PF, Garcia-Revillo J. Efficacy of paclitaxel balloon for hemodialysis stenosis fistulae after one year compared to high-pressure balloons: a controlled, multicentre, randomized trial. Cardiovasc Intervent Radiol. 2020;43(3):382–90.
Article CAS PubMed Google Scholar
Trerotola SO, Lawson J, Roy-Chaudhury P, Saad TF, Lutonix AVCTI. Drug coated balloon angioplasty in failing AV fistulas: a randomized controlled trial. Clin J Am Soc Nephrol. 2018;13(8):1215–24
Trerotola SO, Saad TF, Roy-Chaudhury P, Lutonix AVCTI. The lutonix AV randomized trial of paclitaxel-coated balloons in arteriovenous fistula stenosis: 2-year results and subgroup analysis. J Vasc Interv Radiol. 2020; 31(1):1–14 e15.
Yin Y, Shi Y, Cui T, Li H, Chen J, Zhang L, Yu Z, Li H, Yan Y, Wu K et al. Efficacy and safety of paclitaxel-coated balloon angioplasty for dysfunctional arteriovenous fistulas: a multicenter randomized controlled trial. Am J Kidney Dis. 2021;78(1):19–27 e11
Liao MT, Chen MK, Hsieh MY, Yeh NL, Chien KL, Lin CC, Wu CC, Chie WC. Drug-coated balloon versus conventional balloon angioplasty of hemodialysis arteriovenous fistula or graft: a systematic review and meta-analysis of randomized controlled trials. PLoS ONE. 2020;15(4): e0231463.
Article CAS PubMed PubMed Central Google Scholar
Bjorkman P, Weselius EM, Kokkonen T, Rauta V, Alback A, Venermo M. Drug-coated versus plain balloon angioplasty in arteriovenous fistulas: a randomized, controlled study with 1-year follow-up (The Drecorest Ii-Study). Scand J Surg. 2019;108(1):61–6.
Article CAS PubMed Google Scholar
Kitrou PM, Katsanos K, Spiliopoulos S, Karnabatidis D, Siablis D. Drug-eluting versus plain balloon angioplasty for the treatment of failing dialysis access: final results and cost-effectiveness analysis from a prospective randomized controlled trial (NCT01174472). Eur J Radiol. 2015;84(3):418–23.
Kitrou PM, Spiliopoulos S, Katsanos K, Papachristou E, Siablis D, Karnabatidis D. Paclitaxel-coated versus plain balloon angioplasty for dysfunctional arteriovenous fistulae: one-year results of a prospective randomized controlled trial. J Vasc Interv Radiol. 2015;26(3):348–54.
Swinnen JJ, Hitos K, Kairaitis L, Gruenewald S, Larcos G, Farlow D, Huber D, Cassorla G, Leo C, Villalba LM, et al. Multicentre, randomised, blinded, control trial of drug-eluting balloon vs Sham in recurrent native dialysis fistula stenoses. J Vasc Access. 2019;20(3):260–9.
留言 (0)